Author:

• Aline Doria Sobral Vieira - Vieira, Aline Doria Sobral - Universidade Federal do Estado do Rio de Janeiro, Divisão de Nutrição - <adsvieira@yahoo.com.br>

Co-author(s):

• Glória Regina Mesquita da Silveira - Silveira, Glória Regina Mesquita da - UNIRIO, DNA/ Escola de Nutrição - <regina_me@hotmail.com>

Thematic Area:

Alimentação, Nutrição e Saúde

Abstract:

Objective: Hypertriglyceridemia is common in antiretroviral therapy-treated patients and Omega 3 fatty acids are being used as a intervention in reducing serum triglycerides (TG) in these patients. The objective of this study is to evaluate the effectiveness of the use of Omega 3 in the treatment of hypertriglyceridemia in HIV/AIDS patients on antiretroviral therapy.
Method: This study is a systematic review with meta-analysis of randomized clinical trials. Electronic databases – Pubmed, Cochrane and Lilacs were researched. Results: Fifty one articles were encountered. Nine were added to the meta-analysis. The reduction of triglycerides level was -77.55mg(IC of-121.85 to – 33.25) in Omega 3 groups. The analysis considering trials with more than 1000 mg of EPA/DHA included seven studies and the heterogeneity dropped to 0%.The reduction of combined averages was -101.56mg (IC of -145.76 to -57.37). The analysis considering trials with patients that had more than 200 mg/dL of initial triglycerides included also seven trials and the heterogeneity dropped to 0%. The reduction of combined averages was -114.15mg (IC of -162.34 to -65.97).
Conclusions: EPA/DHA supplementation reduces serum triglycerides levels in patients with HIV/AIDS-associated hypertriglyceridemia in stable use of antiretroviral therapy.

Keywords:

HIVHAARTtriglyceridesomega 3 and fish oil

Content:

Access Issue in Scielo

Other languages: